Sonoclear AS
Peter Balmforth is an experienced executive in the medical technology sector with a strong background in leadership and strategic roles. Currently serving as Chief Executive Officer at SonoClear AS, Balmforth also holds board membership at Digistain® and the position of Executive Director at Asgard Medical Innovations. Previously, Balmforth was Chief Executive Officer of V-Flow Medical, Inc., and Chief Commercial Officer at Pacertool AS, where significant funding was raised for innovative biomarker technology. Previous experience includes roles as Entrepreneur in Residence at SINTEF, Chief Executive Officer at Nisonic AS, and various senior positions at ROX Medical, Atritech, and Ablation Frontiers, contributing to major sales accomplishments and clinical operations in Europe. Balmforth holds a Master’s degree in Human Physiology from Griffith University.
This person is not in any teams
Sonoclear AS
BrainImage is the provider of SonoClear® - an acoustic coupling fluid for enhanced ultrasound imaging. This technology removes surgically induced image artefacts providing basis for enhanced clinical decision support.